Electroceutical Devices Market Analysis, Growth Opportunities and Latest Trends by Leading Regions, and Manufacturers from 2018 to 2026
Electroceuticals
is recently coined term for an old therapeutic modality, which
broadly encompass all the bioelectric medicine. It includes any type
of electrical stimulation, which affects and modify functions of the
body and neural implants such as cochlear implants, retinal implants
or spinal cord stimulators, cardiac pacemakers, and implantable
defibrillators. Over a period of time, electroceutical expanded their
applicability to include deep brain stimulation and the electrical
stimulation of the vagus nerve. Electroceuticals are also called as
bioelectronics, which encompass tiny electronic implants, which are
capable to treat wide range of chronic diseases such as diabetes,
asthma, arthritis, hypertension and other heart ailments, and
gastrointestinal diseases.
Increasing Engagement
of Key Players to Accelerate Drug Discovery and Development Process
is expected to Aid in the Market Growth
Collaborations, advancements in
technology, innovations in the field of bioelectric medicines such as
non-invasive devices are the major factors driving growth of the
bioelectric medicine market. For instance, in October 2016, the U.S.
National Institutes of Health (NIH) announced US$ 20 million funding
for the treatment of disease with electrical stimulation, which aims
to improve maps of the peripheral nervous system—the body’s
electrical wiring—and generate sophisticated systems that can hack
into its codes. Moreover, the funding is part of a US$ 248 million,
seven-year program, which the NIH Common Fund announced in 2014.
Furthermore, in 2016, GlaxoSmithKline
Plc. (GSK) merged with Google’s parent company Alphabet to set up a
new bioelectric company called Galvani Bioelectronics, which will
benefit over 2 billion people suffering from chronic diseases. GSK
invested around US$ 615 million for the development of Galvani
Bioelectronics.
Global Key Players:
Key players operating in
electroceutical devices market include Medtronic plc, Abbott
Laboratories, Cochlear Ltd. Sonova Holding AG, Advanced Bionics AG,
Boston Scientific Corporation, electroCore, Inc., Biotronik,
ReShape Lifesciences, Inc., and LivaNova, PLC.
Inquire
Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1958
Detailed Segmentation:-
Global Electroceutical Devices Market, By Product:
-
Cardiac Pacemakers
-
Implantable Cardioverter Defibrillators
-
Retinal Implants
-
Cochlear Implants
-
Spinal cord Stimulators
-
Deep brain Stimulators
-
Others
-
-
Global Electroceutical Devices Market, By Modality:
-
Implantable Electroceutical Devices
-
Non-Invasive Electroceutical Devices
-
Global Electroceutical Devices Market, By Application:
-
Pain Management
-
Wound Healing
-
Atrial Fibrillation
-
Coronary Artery Disease
-
Diabetes
-
Arthritis
-
Hypertension
-
Gastrointestinal Diseases
-
Other Applications
-
-
Global Electroceutical Devices Market, By End User:
-
Hospitals
-
Academic Research Institutions
-
Ambulatory Surgical Centers
-
-
Global Electroceutical Devices Market, By Geography:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
-
North America
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment